Genetic variation in 5-HT transporter (5-HTT) expression is a key risk factor for psychiatric disorder and has been linked to changes in the expression of certain 5-HT receptor subtypes. This study investigated the effect of variation in 5-HTT expression on 5-HT 4 receptor levels in both 5-HTT knockout (KO) and overexpressing (OE) mice using autoradiography with the selective 5-HT 4 receptor radioligand, 
Introduction
Polymorphic variation in the 5-hydroxytryptamine transporter (5-HTT) gene has been linked to specific personality traits and vulnerability to psychiatric disorder (Greenberg et al. 1999 ; Heils et al. 1996 ; Lesch et al. 1996 ; Rhodes et al. 2007 ). There is a large natural variation in 5-HTT expression in the human population, which may be up to 7-fold between individuals (Lundberg et al. 2007) , and this variation may in part be genetically driven Lesch et al. 1996 ; Ogilvie et al. 1996 ; Ozaki et al. 2003) . Data from animal models strongly support the idea that variation in 5-HTT expression leads to changes in emotionality. For example, across a range of tests, 5-HTT overexpressing (OE) mice display reduced anxiety-like behaviour while homozygous (x/x) 5-HTT knockout (KO) mice show increased anxiety-like behaviour, compared to wild-type mice (Holmes et al. 2002a (Holmes et al. , b, 2003 Jennings et al. 2006) .
Emerging data suggest that variation in 5-HTT expression is linked to adaptive changes in 5-HT receptor function, which theoretically may contribute to the 5-HTT phenotype associations observed in both mice and humans. For instance, x/ x mice display decreased function of the 5-HT 1A autoreceptor in electrophysiological and molecular models (Bouali et al. 2003 ; Gobbi et al. 2001 ; Mannoury la Cour et al. 2001) . Additionally, 5-HT 2A receptor function is downregulated in 5-HTT x/ x mice and up-regulated in Jennings et al. 2008 ; Qu et al. 2005) . Data suggest that such changes in 5-HT receptor expression and function may result from altered extracellular 5-HT levels. Thus, the increased 5-HT 2A receptor function observed in 5-HTT OE mice, which show marked reductions (25-50 % of wild-type) in extracellular 5-HT (Jennings et al. 2006 (Jennings et al. , 2010 , is recapitulated in wild-type mice by 5-HT depletion (Jennings et al. 2008) . Furthermore, 5-HT depletion in 5-HTT x/ x mice, which show enhanced (6-to 8-fold) extracellular 5-HT levels (Fabre et al. 2000 ; Shen et al. 2004) , reverses the down-regulation in 5-HT 2A receptor function observed in these mice (Basselin et al. 2009 ; Fox et al. 2010 ).
The 5-HT 4 receptor is abundant in limbic areas of the brain (Varnas et al. 2003 ; Waeber et al. 1996 ; Warner-Schmidt et al. 2009 ) and plays an important role in anxiety-and depression-like behaviour (Compan et al. 2004 ; Lucas et al. 2007 ; Warner-Schmidt et al. 2009 ). Interestingly, evidence suggests that 5-HT 4 receptor levels are influenced by changes in availability of 5-HT. In particular, an earlier study reported that a 5-HT neuronal lesion increased the abundance of 5-HT 4 receptor binding sites in rat brain (Compan et al. 1996b) , and more recently inhibition of 5-HT synthesis by p-chlorophenylalanine (pCPA) was found to increase 5-HT 4 receptor binding in both pig and rat brain (Ettrup et al. 2011 ; Licht et al. 2009 ). Conversely, repeated administration of selective inhibitors of 5-HTT, which increase extracellular 5-HT availability, decreased the density of 5-HT 4 receptor binding sites and also reduced 5-HT 4 receptor function (Licht et al. 2009 ; Vidal et al. 2009 ).
The present study used 5-HTT
x/ x , heterozygous 5-HTT KO (x/+) and 5-HTT OE mice to test the hypothesis that variation in 5-HTT would lead to changes in 5-HT 4 receptor levels, and that this effect would be an adaptive response to altered availability of 5-HT.
Method

Animals
All experiments were performed in accordance with the Animal (Scientific Procedures) Act 1986 and Home Office and local guidelines concerning the use of animals in research. 5-HTT OE mice and wild-type (WT) littermate controls were bred from female F1 CBAxC57BL6J mice (Charles River, UK) and male 5-HTT OE mice (Jennings et al. 2006) . 5-HTT KO mice (x/x, x/+) and wild-type littermate controls (+/+) were bred from 5-HTT x/ + pairings and maintained on a back-crossed C57BL6J background (Bengel et al. 1998) . Mice were kept on a 12-h light/dark cycle (lights on at 07 : 00 hours) and had free access to laboratory chow, water and nesting materials. All experiments were performed on female mice.
Experimental protocol
An initial study examined the density of 5-HT 4 receptor binding sites in groups of 5-HTT (Bortolozzi et al. 2004 ; Knobelman et al. 2001 ) and the half-life of fluoxetine in rodents is f12 h (Caccia et al. 1990 ; Holladay et al. 1998) .
Mice were killed by cervical dislocation. Drugtreated mice were killed y19 h after the last injection. Brains were removed, frozen in isopentane on dry ice and stored at x80 xC prior to receptor autoradiography.
Receptor autoradiography
Brain tissue sections (12 mm) were cut using a cryostat at the level of the dorsal hippocampus and globus pallidus (figs 40-42 in Franklin & Paxinos, 1997) , thaw-mounted onto gelatinized glass slides, and stored at x80 xC until use. Subsequently, sections were defrosted and air dried for 1 h prior to incubation (room temperature) in Tris buffer (50 mM, pH 7.4) for 15 min followed by incubation for 1 h (room temperature) with the 5-HT 4 receptor selective radioligand, [
3 H]SB207145 (1 nM) in Tris buffer. Sections were then washed in ice-cold Tris buffer (2r20 s) and deionized water (20 s). Non-specific binding was defined by 10 mM RS39604 (Licht et al. 2009 ). After drying in air, slides were apposed to phosphor imaging plates (Fuji, Japan) for 2 wk at 4 xC, and then autoradiograms were developed. Densitometric analysis of the autoradiograms was performed against 3 H microscales (Amersham, UK ; RDA 506) using a computerized imaging system (MCID Core, version 7.0, Interfocus Imaging Ltd, UK).
Data analysis
Statistical analysis was performed on raw data using SPSS v. 16 (SPSS Inc., USA). Two-way repeatedmeasures ANOVA was used to determine the effect of region (repeated measure), genotype and treatment. Significant main effects and interactions were further interrogated using a protected Fisher's LSD test.
Drugs
Fluoxetine HCl was dissolved by gently heating in deionized water and administered i.p. in a volume of 10 ml/kg. pCPA was dissolved in saline (0.9 %) at room temperature and administered i.p. in a volume of 10 ml/kg.
Results
5-HT 4 receptor binding in 5-HTT KO and 5-HTT OE mice
In an initial study, 5-HTT 
5-HT 4 receptor binding in 5-HTT KO mice ; effect of 5-HT synthesis inhibition
A second study was conducted to confirm the decrease in 5-HT 4 receptor binding in 5-HTT KO mice, to extend this to additional brain regions, and to test whether the effect was linked to increased 5-HT availability by using the 5-HT synthesis inhibitor pCPA. In this study, 5-HT 4 receptor binding density varied significantly across brain regions (region : F 5,150 =267, p<0.001) and resembled the pattern described previously (Licht et al. 2009 with high binding density observed in caudate putamen, intermediate binding density in the globus pallidus, hypothalamus and hippocampus (Fig. 1) , and low density in the amygdala and frontal cortex (latter region not quantified).
As shown in Fig. 1 , 5-HTT +/ + vs.
5-HTT
, p>0.14 in all regions).
5-HT 4 receptor binding in 5-HTT OE mice ; effect of 5-HTT blockade
A final study was conducted to confirm the increase in 5-HT 4 receptor binding in 5-HTT OE mice, to extend this to additional brain regions, and to test whether the effect was linked to decreased 5-HT availability by using the 5-HTT blocker fluoxetine.
As shown in Fig. 2 
3).
This effect of fluoxetine to reduce 5-HT 4 receptor binding was observed in both WT and 5-HTT OE (genotypertreatment : F 1,18 =4.6, p<0.05 ; vehicle vs. fluoxetine for WT, p<0.01 and for 5-HTT OE, p<0.001) ; however, the difference in binding between vehicle-and fluoxetine-treated 5-HTT OE mice was much greater that that between vehicle-and fluoxetine-treated WT mice. Furthermore, although 5-HT 4 receptor binding in 5-HTT OE mice remained significantly greater than in WT mice after fluoxetine treatment (genotypertreatment : F 1,18 =4.6, p<0.05 ; WT vs. 5-HTT OE after vehicle, p<0.001 ; WT vs. 5-HTT OE after fluoxetine, p<0.05), the difference between genotypes was smaller after fluoxetine treatment than after vehicle treatment (Fig. 2) .
Discussion
Previous evidence suggests that variation in 5-HTT gene expression is associated with adaptive changes in certain 5-HT receptor subtypes. The present study used 5-HTT KO and OE mice to model variation in 5-HTT gene expression, and investigate its effect on 5-HT 4 receptor binding density. The findings strongly suggest that variation in 5-HTT expression causes marked adaptive changes in 5-HT 4 receptor levels and, moreover, that this effect is directly linked to alterations in 5-HT availability. The present study found that the density of 5-HT 4 receptor binding sites was significantly decreased in 5-HTT
x/ x (but not 5-HTT x/+ ) mice compared to 5-HTT +/ + mice. This effect was observed in two independent experiments and in all brain regions examined (globus pallidus, caudate putamen, hypothalamus, amygdala, dentate gyrus and CA3 layer of the hippocampus). Moreover, the finding of de- that the pCPA regimen used here depleted regional brain tissue 5-HT by 35-55 % in mice (Jennings et al. 2008) , and another group has shown that a similar pCPA treatment regimen decreased brain 5-HT levels in 5-HTT x/ x mice (Fox et al. 2010) .
In accordance with these findings in 5-HTT
x/ x mice, the elevated 5-HT 4 receptor binding in 5-HTT OE mice was reduced by administration of the 5-HTT inhibitor fluoxetine. Previous brain microdialysis and voltammetry data showed that 5-HTT OE mice have decreased (25-50 % of WT) extracellular 5-HT (Jennings et al. 2006 (Jennings et al. , 2010 , which was reversed by local administration of the 5-HTT blocker paroxetine in vivo (Jennings et al. 2006) . Moreover, at systemic doses similar to that used here (20 mg/kg), fluoxetine increased brain extracellular 5-HT in mice (Bortolozzi et al. 2004 ; Knobelman et al. 2001) . Taken together our data suggest that both the increase in 5-HT 4 receptor binding in 5-HTT OE mice, and the decrease in 5-HTT x/ x mice, are likely adaptive changes to altered availability of synaptic 5-HT. This apparent sensitivity of 5-HT 4 receptor binding to altered 5-HT availability was also evident in wildtype mice. Thus, WT mice showed decreased regional brain 5-HT 4 receptor binding in response to fluoxetine administration, as observed previously with fluoxetine and other 5-HTT inhibitors in rats (Licht et al. 2009 ; Vidal et al. 2009 ). In addition, increased 5-HT 4 receptor binding was observed in the dentate gyrus of 5-HTT +/ + mice after pCPA treatment. The fact that no increases were observed after pCPA in other brain regions of 5-HTT +/ + mice may suggest that, under wild-type 5-HTT expression, longer and/or more severe 5-HT depletion (such as that observed in 5-HTT OE mice) is required to induce increased 5-HT 4 receptor binding in other brain regions. Supporting this, one study using a y95 % 5-HT depletion (Kornum et al. 2006) found increased 5-HT 4 receptor binding in hypothalamus, in addition to hippocampus, but not in caudate putamen or globus pallidus (Licht et al. 2009 ). Another study, using total brain 5-HT depletion for 3 wk (Compan et al. 1996a ) reported increased 5-HT 4 receptor binding in caudate putamen, globus pallidus and hippocampus (hypothalamus not examined). Taken together, these studies suggest that in wild-type animals the regional sensitivity of 5-HT 4 receptor binding to 5-HT depletion is dependent on the extent and length of 5-HT depletion. Therefore, the moderate nature of 5-HT depletion induced in the present study (35-55 % ; Jennings et al. 2008) (Vidal et al. 2009 ). The same group reported a similarly close association between outcomes from 5-HT 4 receptor density measurements and the same assays of 5-HT 4 receptor function after repeated treatment with the 5-HT uptake inhibitor venlafaxine (Vidal et al. 2010) . It is noteworthy that the magnitude of the decrease in hippocampal 5-HT 4 receptor binding (x40 %) after fluoxetine and venlafaxine that translated into a decrease in 5-HT 4 receptor function, is even less than that observed here in 5-HTT x/ x mice (x47 %). Both 5-HTT x/ x and OE mice have strong behavioural phenotypes, which may in part be linked to altered 5-HT 4 receptor levels. In this regard it is of particular interest that 5-HT 4 receptor binding in the amygdala of 5-HTT x/ x mice was decreased. The amygdala is critical in the acquisition of learned fear (Sah et al. 2008 ; Sigurdsson et al. 2007) , and 5-HT 4 receptor signalling in this region has been shown to facilitate a form of synaptic plasticity linked to the long-term memory for learned fear (Huang & Kandel, 2007) . In this respect it is highly relevant that 5-HTT x/ x mice demonstrate an abnormal fear phenotype, showing reduced fear extinction recall (Wellman et al. 2007) . It is tempting to hypothesize that altered 5-HT 4 binding in the amygdala contributes to this fear phenotype. Although, it should be noted that reported adaptive changes in other 5-HT receptor subtypes (e.g. 5-HT 1A and 5-HT 2A ) in 5-HTT x/ x mice might also impact on behaviour (Basselin et al. 2009 ; Fabre et al. 2000 ; Fox et al. 2010 ).
In the amygdala of 5-HTT OE mice, a significant increase in 5-HT 4 receptor binding vs. WT was not observed. This lack of significance may have arisen from the low expression levels in the amygdala confounding the analysis as there is no reason to believe that the 5-HT 4 receptor should be regulated differently in 5-HTT OE mice in this region compared to others.
In the context of the present findings it is noteworthy that a 5-HT 4 receptor selective PET radioligand, [
11 C]SB207145, has recently been developed for human use (Marner et al. 2009 (Marner et al. , 2010 , thereby offering the prospect of correlating individual 5-HTT binding with that of 5-HT 4 receptors. Indeed, a recent PET study examining 5-HT 2A receptor and 5-HTT binding in parallel demonstrated a strong correlative relationship between the two , thereby adding clinical relevance to the idea that 5-HTT variation influences 5-HT receptor subtypes. The current and previous evidence that 5-HT 4 receptor binding is responsive to changes in 5-HT availability is also highly relevant to the ongoing search for a PET biomarker of brain 5-HT release in vivo (Paterson et al. 2010) . While available data indicate that 5-HT 4 receptor radioligands like [
11 C]SB207145 might not be displaceable by acute, dynamic changes in 5-HT availability (Marner et al. 2009 (Marner et al. , 2010 , the current findings point to the potential of such radioligands for detecting changes in 5-HT availability which are gradual and long-lasting.
In summary, findings in the current study indicate that genetic variation in 5-HTT expression is associated with alterations in the density of 5-HT 4 receptor binding, with low 5-HTT expression associated with decreased 5-HT 4 receptor binding and vice versa. Moreover, the data suggest that the changes in density of 5-HT 4 receptor binding are an adaptive response to altered availability of 5-HT. These observations predict that the large naturally occurring variation in 5-HTT levels in the human population may be associated with variation in 5-HT 4 receptor levels that may contribute to 5-HTT-linked behavioural phenotypes.
